Vollständiger Abstract
Worum geht es in dieser Arbeit?
A 54-year-old man with progressive small cell lung cancer underwent ¹⁸F-FDG and ⁶⁸Ga-DOTATATE PET/CT before radionuclide therapy. ¹⁸F-FDG PET/CT evaluated disease extent and identified metabolically active lesions. ⁶⁸Ga-DOTATATE PET/CT showed high SSTR expression in bone lesions and the pancreatic tail. Discordant hepatic uptake suggested tumor heterogeneity. The two scans provided complementary information on disease activity and therapeutic target expression, supporting patient selection and individualized planning for an SSTR-targeted radionuclide therapy–based comprehensive treatment strategy.
Bibliografischer Nachweis
Publikationsdaten
- Autor:innen
- Shijie Tang, Qinglin Lei, Ya Liu, Yanggang Liu, Lin Qiu
- Quelle
- Clinical Nuclear Medicine
- Publikation
- 2026-01-01
- Band / Ausgabe
- Nicht angegeben
- Seiten
- Nicht angegeben
- ISSN / ISBN
- 0363-9762, 1536-0229
- Zitationen
- 0 laut Crossref
- Referenzen
- 0 hinterlegt
Zitieren
Zitierfähiger Nachweis
Shijie Tang, Qinglin Lei, Ya Liu, Yanggang Liu, Lin Qiu (2026). Discordant ¹⁸F-FDG and ⁶⁸Ga-DOTATATE PET/CT Findings Before Radionuclide Therapy in Small Cell Lung Cancer. Clinical Nuclear Medicine. https://doi.org/10.1097/rlu.0000000000006656